Pediatric Meningococcal Vaccine's Approval Pathway May Work For Other Disease Areas
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA suggests serum bactericidal antibody measurements to predict protection from meningococcal diseases in children under age 2.